911432-25-2

Upstream product

• 368870-20-6 5-[(methoxymethylene)amino]-1-[5-O-(tert-butyldimethylsilyl)-2,3-O-(isopropylidene)-β-D-ribofuranosyl]imidazole-4-nitrile 
• 2508-29-4 5-hydroxypentylamine 
• 911432-17-2 N¹-(5''-monomethoxytrityloxypentyl)-5'-O-tert-butyldimethylsilyl-2',3'-O-isopropylideneadenosine 
• 911432-12-7 N¹-[(5''-hydroxy)pentyl]-5'-O-tert-butyldimethylsilyl-2',3'-O-isopropylideneadenosine 
• 911432-21-8 N¹-(5''-monomethoxytrityloxypentyl)-2',3'-O-isopropylideneadenosine 
• 67941-87-1 cyclohexylammonium S,S-diphenyl phosphorodithioate 

Downstream Products

• 911432-35-4 N¹-(5''-phosphonoxypentyl)-5'-O-[(phenylthio)phosphoryl]-2',3'-O-isopropylideneadenosine 
• 911432-29-6 N¹-[(5''-hydroxy)pentyl]-5'-O-[bis(phenylthio)phosphoryl]-2',3'-O-isopropylideneadenosine 

Relevant academic research and scientific papers

Synthesis and agonist activity of cyclic ADP-ribose analogues with substitution of the northern ribose by ether or alkane chains

Novel analogues of cADPR with adenine as base and ether (10a) or different alkane chain (10b-d) substitutions of the northern ribose were synthesized from protected imidazole nucleoside 1 in good yields. The pharmacological activities of cyclic inosine di